Community Based Surveillance for AMR Monitoring: Significance, Requirements and Feasibility in LMICS
By Afreenish Amir
Community based surveillance, in addition to clinical antimicrobial resistance (AMR) surveillance, plays an essential role in AMR and antimicrobial use trend monitoring. Various community-based AMR surveillance studies to monitor trends in AMR and use of antimicrobials have been conducted and shown its potential to facilitate evidence-based interventions and policy making for control of AMR. Many low and middle income countries (LMICs) lack the necessary systems and resources to establish effective surveillance systems. Specifically, the surveillance capacity at hospitals and other health facilities is limited, and the overall human resource capacity for community-level data collection, analysis, and multi-sectoral coordination is severely constrained. Prior to planning for community based AMR surveillance, a country should have established mechanisms to run the system efficiently, including strong governance and regulations, surveillance infrastructure, laboratory capacities, skilled human resources, data collection and management, funding and sustainability.
The World Health Organization and quadripartite partners have recommended advancing community based AMR surveillance in LMICs, and integrated AMR surveillance combining information from humans, animals and ecosystems, which seems a challenge in the current situation. Considering the significant gaps in systems, resources, and capacities, it is important to prioritize strengthening the country’s core capacities and addressing the underlying gaps in healthcare systems. Efforts should focus on enhancing the country’s core capacities, systems, and technical requirements while exploring the potential of advancing selective community based AMR surveillance interventions and systems in the future.
Gender Intersectionality in Antimicrobial Resistance
Webinar Report
The South Centre held a webinar on Gender Intersectionality in Antimicrobial Resistance (AMR), on 14 May 2025, with the participation of experts from academia, independent research institutions and international organizations. The webinar was attended by over 70 participants from around the world, demonstrating interest in gaining greater understanding of the gender dimension in effective strategies fortackling antimicrobial resistance.
Designing an Independent Panel onEvidence for Action on Antimicrobial Resistance: Lessons from Selected Bodies in Global Health, Climate Change and Biodiversity
By Viviana Munoz Tellez and Francesca Chiara
This paper proposes a framework for designing an Independent Panel on Evidence for Action on Antimicrobial Resistance (IPEA), responding to the 2025 United Nations General Assembly mandate. Through a comparative analysis of selected international scientific advisory bodies, we identify the panel’s mandate as the foundational element that will critically shape its composition, scope, deliverables, and governance structure. Our framework addresses key domains of credibility, scientific integrity, authority, policy relevance, and sustainability while establishing equity as a fundamental design principle—not merely ensuring low and middle-income country (LMIC) participation but designing the IPEA to address existing imbalances in antimicrobial resistance (AMR) evidence production and dissemination. We analyse potential mandate options, from evidence synthesis to policy recommendations, highlighting the importance of defining a unique and complementary role for IPEA within the existing AMR governance landscape to avoid duplication and maximize impact on global AMR response.
Policy in Practice: Implementing Antimicrobial Stewardship Post-COVID-19
Q&A and Commentary
By Dr Rasha Abdelsalam Elshenawy
This report summarises the key questions and expert commentary for the South Centre, as well as the South Centre Policy Brief on lessons from the COVID-19 pandemic, to strengthen antimicrobial stewardship and provide practical recommendations discussed during the South Centre webinar on “Strengthening Antimicrobial Stewardship: Policy Insights from COVID-19 and Future Pandemic Preparedness.”
From global to local action: Operationalising AMR commitments in Africa and beyond
11-12 June 2025
Lusaka, Zambia
The ReAct Africa-South Centre Annual Conference 2025 aims to translate these global and regional commitments into actionable strategies for local and national contexts in low- and middle-income countries; with a specific focus on Africa’s needs and priorities. It will serve as a platform for key stakeholders from, but not limited to governments at the regional, national and sub-national levels
A great variety of stakeholders will join the conference in Lusaka: International & regional organizations (Quadripartite organs – FAO, WHO, WOAH & UNEP; Africa CDC, ECSA-HC, etc.), public health professionals and health practitioners, civil society and community organizations, academia and research institutions, youth in AMR, faith sector, private sector leaders and innovators, media and communication experts.
Statement by the South Centre to the Seventy-eighth World Health Assembly
Agenda Item 15: Antimicrobial Resistance
27 May 2025
The South Centre strongly encourages member States and the Director General to maintain antimicrobial resistance as a WHO priority, with adequate resources in headquarters and regional offices, and increased coherence as a cross cutting issue across various WHO programmes …
Gender Intersectionality in Antimicrobial Resistance
Date & Time: 14 May 2025, 4PM CET Geneva time / 10AM EST / 2PM GMT
Key Discussion Points:
The intersectionality of gender with other social determinants (e.g. socioeconomic status, education, occupation) in shaping AMR vulnerabilities and outcomes.
How gender influences antibiotic use, access to healthcare, and infection prevention and control practices?
Strategies for integrating gender-sensitive approaches into AMR policies, programs, and research
The South Centre is seeking to fill a consultancy position to support its activities in the area of tackling antimicrobial resistance in developing countries.
The Consultant will be engaged on a full or part-time basis by the South Centre under a Special Service Agreement (SSA) for a period of 6 months.
The place of assignment is Geneva, Switzerland, or from a remote location.
Strengthening Antimicrobial Stewardship Policy: Insights from COVID-19 and Future Pandemic Preparedness
South Centre Webinar
Date: 14 April 2025 Time: 12:00 PM – 1:00 PM CEST | 6:00 AM – 7:00 AM EDT | 3:30 PM – 4:30 PM IST Location: Virtual (Zoom)
In this one-hour webinar, we will explore how the COVID-19 pandemic impacted antimicrobial stewardship (AMS) programmes and what lessons can strengthen future pandemic preparedness, especially in low- and middle-income countries (LMICs).
Advancing National Action Plans on Antimicrobial Resistance amidst Health Financing Challenges
By Afreenish Amir
The South Centre held a webinar on advancing national action plans (NAPs) on Antimicrobial Resistance (AMR) amidst health financial challenges, on 20 March 2025. The webinar brought together various national focal point leads for NAPs on AMR and international experts.